Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001193125-26-144196

Chief Executive Officer acquired 62,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Collard Craig A · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-03 Exercise or conversion : show line 1 in the form +62,500 648,255 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-03 Exercise or conversion : show line 2 in the form Restricted Stock Units −62,500 62,500 D
Loading xslF345X06/ownership.xml…